Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Nacson

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature Communications|December 13, 2019
BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistanceYifan Wang, Andrea J Bernhardy, Joseph Nacson, et al.
Molecular Cell|May 4, 2020
BRCA1 Mutational Complementation Induces Synthetic ViabilityJoseph Nacson, Daniela Di Marcantonio, Yifan Wang, et al.
Cell Reports|November 1, 2018
BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor ResistanceJoseph Nacson, John J Krais, Andrea J Bernhardy, et al.
Cell Reports|September 27, 2018
BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor ResistanceJoseph Nacson, John J Krais, Andrea J Bernhardy, et al.
Nature Communications|November 24, 2023
Genetic separation of Brca1 functions reveal mutation-dependent Polθ vulnerabilitiesJohn J Krais, David J Glass, Ilse Chudoba, et al.
Molecular Cell|October 16, 2025
PALB2 and 53BP1 govern post-resection homologous recombination DNA repairYifan Wang, Yan Coulombe, Wei-Ting Yueh, et al.
Molecular Cell|August 1, 2025
PALB2 and 53BP1 govern post-resection homologous recombination DNA repairYifan Wang, Yan Coulombe, Wei-Ting Yueh, et al.
Cancer Research|July 3, 2021
<i>TET2</i> and <i>DNMT3A</i> Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP InhibitorsSilvia Maifrede, Bac Viet Le, Margaret Nieborowska-Skorska, et al.
Cancer Research|May 20, 2016
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and CisplatinYifan Wang, Andrea J Bernhardy, Cristina Cruz, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Communications|December 13, 2019
BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistanceYifan Wang, Andrea J Bernhardy, Joseph Nacson, et al.
Molecular Cell|May 4, 2020
BRCA1 Mutational Complementation Induces Synthetic ViabilityJoseph Nacson, Daniela Di Marcantonio, Yifan Wang, et al.
Cell Reports|November 1, 2018
BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor ResistanceJoseph Nacson, John J Krais, Andrea J Bernhardy, et al.
Cell Reports|September 27, 2018
BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor ResistanceJoseph Nacson, John J Krais, Andrea J Bernhardy, et al.
Nature Communications|November 24, 2023
Genetic separation of Brca1 functions reveal mutation-dependent Polθ vulnerabilitiesJohn J Krais, David J Glass, Ilse Chudoba, et al.
Molecular Cell|October 16, 2025
PALB2 and 53BP1 govern post-resection homologous recombination DNA repairYifan Wang, Yan Coulombe, Wei-Ting Yueh, et al.
Molecular Cell|August 1, 2025
PALB2 and 53BP1 govern post-resection homologous recombination DNA repairYifan Wang, Yan Coulombe, Wei-Ting Yueh, et al.
Cancer Research|July 3, 2021
<i>TET2</i> and <i>DNMT3A</i> Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP InhibitorsSilvia Maifrede, Bac Viet Le, Margaret Nieborowska-Skorska, et al.
Cancer Research|May 20, 2016
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and CisplatinYifan Wang, Andrea J Bernhardy, Cristina Cruz, et al.
Pageof 1